This article explores current health trends, including the rise of popular clinics, the debate around weight loss jabs, dietary changes by a dietitian, and direct sales of obesity drugs. Read more...

Novo Nordisk and Eli Lilly are battling it out in the weight-loss drug market with price cuts on Wegovy and Zepbound. Also, investment firms adjust their positions in KKR and Blue Owl. Read more...

Recent business news covers mortgage implications after house destruction, wealth-building strategies, prescription drug price cuts, and the rise and fall of Forever 21. Read more...

Recent analyst reports show positive momentum for YETI, ON Semiconductor, and Eli Lilly, with raised price targets and continued "overweight" ratings. Plus, a look at Caterpillar as a potential dividend stock. Read more...